Table 2 Features and distribution of treatment modalities
From: Long-term functional outcome after laryngeal cancer treatment
Treatment Parameters | Primary Treatment Modality | |
|---|---|---|
Surgery | (Chemo)Radiotherapy | |
n = 118 (24.7%) | n = 359 (75.3%) | |
Transoral laser microsurgery | 62 (52.5%) | |
Partial open laryngectomy | 17 (14.4%) | |
Total laryngectomy | 39 (33.1%) | |
Neck Dissection | 62 (52.5%) | 25 (7%)a |
Adjuvant treatment | 69 (58.5%) | |
Radiotherapy technique | ||
conventional 2-dimensional | 8 (11.6%) | 9 (2.5%) |
conventional 3-dimensional | 47 (68.1%) | 230 (64.1%) |
static field intensity modulated | 10 (14.5%) | 48 (13.4%) |
volumetric modulated arc | 4 (5.8%) | 72 (20.1%) |
Median total dose in Gy (range) | 66 (60–72) | 70 (64–76) |
Median duration of radiotherapy in days (range) | 46 (36–59) | 49 (39–71) |
Induction chemotherapy | 2 (1.7%) | 9 (2.5%) |
Concomitant systemic therapy | 19 (27.5%) | 92 (25.6%) |
Cisplatin 3w | 15 (78.9%) | 61 (66.3%) |
Carboplatin + 5-fluorouracil 3w | 2 (10.5%) | 7 (7.6%) |
Cetuximab weekly | 2 (10.5%) | 24 (26.1%) |